Submitted by Anonymous (not verified) on 6 May 2025 - 10:40
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised